Great response and thinking by mgmt and BOD.
Charlie Munger said that “the only job of the BOD is to deepen the moat”. Risk management is anyway the mgmt and BOD responsibility.
Bisantrene trials deepens the moat and increases the value in the company. Mgmt is taking actions by building the team both internally and externally which mitigates the risk of what Dr.T has articulated above and in general regarding execution risk. We can clearly see that mgmt and BOD are doing everything possible to ensure success of trials and highest value realisation for the benefit of SH.
but out price, page-147
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.010(0.59%) |
Mkt cap ! $291.1M | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.75 | $1.70 | $226.9K | 131.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9599 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 4886 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |